[Therapy of systemic lupus erythematosus using a cytostatic agent of the ethyleneimine group].
D000293:Adolescent; D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced; D002648:Child; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008875:Middle Aged; D013921:Thrombocytopenia / Q000139:chemically induced; D014228:Triaziquone / Q000008:administration & dosage* / Q000009:adverse effects
D014228:Triaziquone
Behandlung des systematisierten Lupus Erythematodes mit einem Zytostatikum der Athylenimin-Gruppe.